EFTR BRIEF-eFFECTOR Therapeutics Announces $7.5 Mln Registered Direct Offering Priced At-The-Market Under Nasdaq Rules * EFFECTOR THERAPEUTICS ANNOUNCES $7.5 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES * EFFECTOR THERAPEUTICS(EFTR) - ENTERED DEFINITIVE DEAL WITH SINGLE INSTITUTIONAL INVESTOR FOR PURCHASE AND SALE OF 11.5MLN SHARES OF ITS COMMON STOCK * EFFECTOR THERAPEUTICS INC(EFTR) - DEFINITIVE AGREEMENT AT PURCHASE PRICE OF $0.655 PER SHARE * EFFECTOR THERAPEUTICS INC(EFTR) - GROSS PROCEEDS TO CO FROM OFFERING ARE EXPECTED TO BE ABOUT $7.5 MILLION